Clopidogrel Krka (clopidogrel)
Generic
- Region
- 🇪🇺 EU
- Active substance
- clopidogrel
- Company
- KRKA tovarna zdravil d.d. Novo mesto
- Status
- Authorised
- Therapeutic area
- Peripheral Vascular Diseases; Stroke; Myocardial Infarction
- CHMP opinion
- Thu 25 Jun 2009
- EU approval
- Wed 23 Sep 2009
- Designations
- Generic
- Application
- EMEA/H/C/001056
- ATC
- B01AC04
- Official record
- www.ema.europa.eu
Indication
Clopidogrel is indicated in adults for the prevention of atherothrombotic events in: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 DuoPlavin Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Clopidogrel Zentiva (previously Clopidogrel Winthrop) Authorised · Zentiva k.s.
- 🇪🇺 Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Authorised · Viatris Limited
- 🇪🇺 Iscover Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Plavix Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Grepid Authorised · Pharmathen S.A.
- 🇪🇺 Clopidogrel Krka d.d. (previously Zopya) Authorised · Norpharm Regulatory Services Ltd
- 🇪🇺 Clopidogrel TAD Authorised · Tad Pharma GmbH
- 🇪🇺 Zyllt Authorised · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) Authorised · Mylan Pharmaceuticals Limited
- 🇪🇺 Clopidogrel ratiopharm Authorised · Teva B.V.
- 🇪🇺 Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Authorised · Taw Pharma (Ireland) Limited
Follow Clopidogrel Krka
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.